Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07919067). This is a study registration, not published results. Lead sponsor: Kasr El Aini Hospital. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 160 participants (ACTUAL). Conditions: Severe Obesity, Port-Site Hernia, Postoperative Pain. Interventions: PROCEDURE: Non-closure of working port fascia (skin closure only); PROCEDURE: Fascial closure of working ports. Primary outcome measures: Incidence of port-site hernia , 12 months after surgery. Brief summary: This randomized controlled trial compared closure versus non-closure of the fascia at the working port (trocar) sites during laparoscopic sleeve gastrectomy for severe obesity. A total of 160 adult patients undergoing laparoscopic sleeve gastrectomy at Kasr Al Ainy Hospital, Cairo University, were randomly allocated (1:1) to non-closure of the working ports (skin closure only) or fascial closure of the working ports using a fascial closure device. Patients were followed for one year for the development of port-site hernia. Postoperative pain was assessed with the Visual Analogue Scale (VAS) at one week and one month, and functional recovery with the Quality of Recovery-15 (QoR-15) score at one week.